Skip to content
2000
Volume 13, Issue 8
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Marine Cyanobacteria have raised growing attention as sources of bioactive “secondary metabolites” that originate from mixed biosynthetic pathways. Some of these molecules exhibit antitumour activities with unique mechanism of action. This mini-review focuses specifically on new molecules that may act as leads for novel drug development.

© Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdt/10.2174/138945012802009035
2012-07-01
2025-09-29

  • From This Site

    /content/journals/cdt/10.2174/138945012802009035
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/138945012802009035
Loading

  • Article Type:     Research Article
Keyword(s): antitumour drugs; Apratoxins; bisebromoamide; coibamide; Cyanobacteria; largazole; lyngbya; marine macrorganisms; secondary metabolites; symploca

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test